US · RDNT
RadNet, Inc.
- Sector
- Healthcare · Medical - Diagnostics & Research
- Headquarters
- Los Angeles, CA 90025-3303
- Website
- radnet.com
Price · as of 2024-12-31
$56.85
Market cap 5.4B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $35.68 | -37.24% |
| Intrinsic Value(DCF) | $26.69 | -53.05% |
| Graham-Dodd Method(GD) | $2.82 | -95.05% |
| Graham Formula(GF) | $0.79 | -98.6% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $3.49 | $22.82 | $23.17 | $0.00 | $0.00 |
| 2011 | $3.45 | $28.50 | $2.61 | $0.00 | $3.98 |
| 2012 | $2.74 | $25.47 | $0.00 | $3.34 | $21.09 |
| 2013 | $2.82 | $21.33 | $0.00 | $0.00 | $0.89 |
| 2014 | $8.99 | $28.43 | $0.00 | $0.00 | $0.34 |
| 2015 | $6.19 | $20.60 | $0.00 | $0.00 | $3.58 |
| 2016 | $5.35 | $18.10 | $0.00 | $0.00 | $2.65 |
| 2017 | $11.80 | $22.41 | $0.00 | $0.00 | $0.01 |
| 2018 | $13.48 | $33.26 | $0.00 | $0.00 | $9.17 |
| 2019 | $19.40 | $22.99 | $17.71 | $0.00 | $7.64 |
| 2020 | $23.87 | $20.10 | $2.31 | $0.00 | $0.00 |
| 2021 | $20.78 | $95.63 | $1.22 | $0.00 | $14.01 |
| 2022 | $23.39 | $19.27 | $0.00 | $0.00 | $3.13 |
| 2023 | $46.51 | $28.94 | $11.78 | $0.00 | $0.98 |
| 2024 | $50.31 | $35.68 | $8.83 | $2.81 | $0.79 |
AI valuation
Our deep-learning model estimates RadNet, Inc.'s (RDNT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $35.68
- Current price
- $56.85
- AI upside
- -37.24%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$26.69
-53.05% upside
Graham-Dodd
$2.82
-95.05% upside
Graham Formula
$0.79
-98.6% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| RDNT | RadNet, Inc. | $56.85 | 5.4B | -37% | -53% | -95% | -99% | 94.62 | 4.07 | 2.01 | 17.76 | — | 33.32 | 13.62% | 5.72% | 0.15% | 5.07% | 4.94% | 1.30% | 1.92 | 1.31 | 2.12 | 2.02 | 3.77 | -2059.00% | 1318.00% | 156.00% | 1.22% | 0.49 | 2.45% | 0.00% | 0.00% | 4.35% | 44.57 | 103.74 | 2.55 | 1.85 |
| BLCO | Bausch + Lomb Corporation | $18.30 | 6.48B | +52% | -60% | — | — | -18.50 | 1.01 | 1.28 | 20.11 | -138.78 | -4.09 | 58.71% | 3.12% | -7.06% | -5.45% | 1.41% | -2.56% | 0.83 | 0.37 | 1.55 | 0.84 | 8.72 | 1333.00% | 647.00% | 1186.00% | -1.01% | 0.15 | -0.59% | 0.00% | 0.00% | 0.00% | 72.33 | -174.25 | 2.25 | 0.92 |
| BRKR | Bruker Corporation | $40.11 | 6.09B | -2% | -60% | -66% | — | 206.96 | 2.44 | 1.76 | 17.43 | — | -7.46 | 45.61% | 6.30% | -0.25% | 1.37% | 2.20% | 0.48% | 0.76 | 4.69 | 1.73 | 0.66 | 3.59 | -11974.00% | 208.00% | -6816.00% | 0.72% | 0.10 | 1.10% | 0.38% | 78.10% | 8.68% | 35.15 | 175.83 | 2.22 | 1.82 |
| BTSG | BrightSpring Health Servi… | $41.43 | 7.47B | +60% | +485% | -97% | -50% | 44.17 | 4.49 | 0.65 | 24.32 | — | -6.86 | 11.76% | 3.06% | 1.48% | 10.82% | 6.59% | 3.09% | 1.52 | 2.51 | 1.57 | 0.58 | 5.99 | -102949.00% | 1459.00% | -79075.00% | 4.69% | 0.27 | 8.65% | 0.00% | 0.00% | 1.57% | 28.26 | 28.32 | 0.87 | 3.51 |
| CHE | Chemed Corporation | $410.01 | 5.97B | -25% | -56% | -80% | -46% | 22.87 | 6.19 | 2.40 | 14.53 | — | 26.42 | 29.97% | 13.37% | 10.48% | 25.28% | 23.68% | 16.54% | 0.15 | 193.28 | 1.05 | 0.90 | 0.16 | -739.00% | 406.00% | -1155.00% | 5.36% | 1.35 | 30.56% | 0.52% | 11.90% | 7.63% | 18.14 | 18.85 | 2.43 | 9.79 |
| IRTC | iRhythm Technologies, Inc… | $133.75 | 4.32B | -14% | +116% | — | — | -92.28 | 26.92 | 5.50 | -1074.06 | — | 27.07 | 70.57% | -4.93% | -5.96% | -36.57% | -12.43% | -4.57% | 4.79 | -2.80 | 4.63 | 4.34 | -124.89 | -6171.00% | 2624.00% | -21299.00% | 0.84% | 0.53 | 11.65% | 0.00% | 0.00% | 0.00% | -115.69 | 123.36 | 5.70 | 3.00 |
| KRYS | Krystal Biotech, Inc. | $275.64 | 8.06B | -24% | -34% | -72% | +4% | 36.57 | 6.14 | 19.25 | 39.75 | 28.57 | 6.14 | 92.61% | 41.45% | 52.64% | 18.91% | 42.60% | 17.14% | 0.01 | — | 9.95 | 9.28 | -2.90 | 12800.00% | 3394.00% | 5851.00% | 2.52% | 1.95 | 49.90% | 0.00% | 0.00% | 1.99% | 41.37 | 35.32 | 17.15 | 40.89 |
| MMSI | Merit Medical Systems, In… | $77.18 | 4.58B | +4% | -60% | -62% | -45% | 35.22 | 2.86 | 2.99 | 14.98 | 715.00 | 8.38 | 48.70% | 12.19% | 8.48% | 8.67% | 7.25% | 5.03% | 0.57 | 6.98 | 4.34 | 2.80 | 1.35 | 493.00% | 1175.00% | 1800.00% | 4.77% | 1.24 | 11.26% | 0.00% | 0.00% | 0.00% | 26.93 | 23.07 | 3.28 | 4.04 |
| MTSR | Metsera, Inc. | $70.50 | 7.43B | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | -108.40% | 1345.61% | -67.48% | 0.03 | -1008.22 | 5.34 | 5.24 | 1.57 | 10947.00% | — | 18254.00% | — | -1.49 | 625.73% | — | 0.00% | — | — | — | — | — |
| SHC | Sotera Health Company | $16.25 | 4.62B | +100% | -39% | — | -77% | 57.96 | 7.45 | 3.88 | 21.25 | 84.30 | -5.75 | 55.48% | 33.75% | 6.70% | 15.42% | 8.28% | 2.46% | 3.75 | 2.52 | 2.46 | 1.95 | 6.36 | 6875.00% | 574.00% | 23081.00% | 3.30% | 1.15 | 5.95% | 0.00% | 0.00% | 3.24% | 16.41 | 43.20 | 5.54 | 1.68 |
| TFX | Teleflex Incorporated | $122.06 | 5.39B | -20% | -55% | — | +315% | -6.06 | 1.76 | 2.75 | 17.49 | — | -7.79 | 56.24% | 2.94% | -45.45% | -24.47% | 1.35% | -12.90% | 0.06 | 0.58 | 2.54 | 0.95 | -0.64 | -146824.00% | -3461.00% | -9972.00% | 0.03% | 0.13 | 0.03% | 1.10% | -6.70% | 36.82% | 90.40 | 3659.08 | 2.66 | 2.01 |
About RadNet, Inc.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
- CEO
- Howard G. Berger
- Employees
- 11K
- Beta
- 1.49
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($26.69 ÷ $56.85) − 1 = -53.05% (DCF, example).